Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 20 Life Science Startup Investors in Singapore in January 2026

Last updated: Jan 2026 A list of 20 angel investors and VC (Venture Capital) funds that invest in Life science startups based in Singapore. We rank investors based on the number of investments they made in Life science companies from Singapore. We update this investor list every month.

Top 20 Life Science Startup Investors in Singapore in January 2026

Investor	Life Science Singapore investments
Eisai	2
EDBI	2
Temasek Holdings	1
Altara Ventures	1
Seeds Capital	1
KT Investment	1
Hana Financial Investment	1
Prox Ventures	1
Nestle	1
Lightstone Ventures	1
M Capital Partners	1
The Venture Collective	1
Anzu Partners	1
K3 Ventures	1
SK Securities	1
Partners Investment	1
KB Financial Group	1
Amgen Ventures	1
UTEC - The University of Tokyo Edge Capital Partners	1
Openspace Capital	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Eisai is a pharmaceutical company that researches and delivers medicines for patients.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series C, Funding Round
Japan, United States, China

Portfolio highlights

Seed Therapeutics — Seed Therapeutics is a biotech company that focuses on harnessing and engineering molecules.
Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
Lifenet Insurance Company — LIFENET INSURANCE COMPANY offers a range of insurance underwriting and asset management solutions. Its insurance products include death, medical, and disability insurance. The company also provides health counselling services. LIFENET INSURANCE COMPANY was founded in October 2006.

EDBI invests in high growth technology sectors. EDBI Creates value and empowers companies to build sustainable legacies.

Investment focus

Biotechnology, Software, Health Care
Series C, Series B, Series D
United States, Singapore, India

Portfolio highlights

Paxata — The DataRobot End-of-Life (EOL) policy helps manage product lifecycle phases in a way that is transparent and clear for customers who will seamlessly transition to a new product or service.
Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.
Callio Therapeutics — Callio Therapeutics focuses on developing next-generation, multi-payload antibody-drug conjugates to maximize therapeutic benefits.

Temasek is a global investment company headquartered in Singapore with a multinational staff of over 960 people. Our portfolio is valued at S$434 billion.

Investment focus

Biotechnology, Health Care, Software
Series B, Series C, Series D
United States, China, India

Portfolio highlights

Glympse Bio — Glympse Bio is developing a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases. The company’s technology uses precisely engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. Glympse Bio’s platformtechnology was originally developed at MIT, and is founded by a team of world-renowned experts in nanomedicine and biomedical engineering.
Impossible Foods — Impossible Foods focuses on developing plant-based substitutes for meat, dairy, and fish products. It selects specific proteins and nutrients from greens, seeds, and grains to recreate the experience of meats and dairy products. Founded by Patrick Brown and Monte Casino in 2011, Impossible Foods is headquartered in Redwood City, California.
LeapFrog Investments — Scaling purpose-driven businesses to achieve leaps of growth, profitability and impact.

Singapore-based venture firm backing Series A & B companies across Southeast Asia. Built by operators for founders who understand the long climb. Global perspective, local instincts.

Investment focus

Software, FinTech, Information Technology
Series A, Series B, Seed
Singapore, Indonesia, South Korea

Portfolio highlights

Allra — Allra is a financial management platform for online SMEs.
Buyandship — Buyandship provides cross-border eCommerce solution focusing on Marketing and Logistics. At Buyandship, is redefining the experience of E-Commerce without changing the sites, disrupting the underlying infrastructure, we provide consolidate, aggregate and load-balance shipments across the world to the consumer's doorstep. Our technologyfocuses on connecting the fragmented existing logistics infrastructure to create a seamless experience for both merchants and consumers, and the benefit is that they get a solution that is 30-50% less than other carriers. We also work with merchants, marketplaces, and platforms to create a channel to reach an audience across our geographies (9 Countries currently) and reaching over 1.5M+ people per month whilst growing. We envision our members being able to purchase from any site around the world and have it seamlessly be shipped home. No more geographical restrictions, No more price monopolies, No more ambiguous shipping situations. We are building towards a transparent system, where both buyers and sellers just focus on the product.
Klinik Pintar — Klinik Pintar membantu pasien mendapatkan layanan kesehatan primer terbaik di klinik, rumah, dan kantor.

Catalysing smart monies into Singapore-based, early-stage technology startups.

Investment focus

Software, Biotechnology, Health Care
Seed, Series A, Funding Round
Singapore, United States, Hong Kong

Portfolio highlights

Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
Atomionics — Atomionics is building atomic sensors for navigation and resource exploration. Sensing technology is severely inadequate for a lot of applications navigation and positioning, pinpointing oil and gas reserves, tunnel detection etc. Atomionics builds atomic sensors harnessing quantum mechanical properties of the atoms. This enables measurement ofparameters like gravity, acceleration and rotation with 1000x higher precision and accuracy than the current state of the art, leading to a completely new way of global positioning, and resource exploration.
Callio Therapeutics — Callio Therapeutics focuses on developing next-generation, multi-payload antibody-drug conjugates to maximize therapeutic benefits.

KT Investment, established in 2015 as the venture capital arm of KT Group, is dedicated to driving social impact while achieving maximum investment returns. We stand with founders every step of the way, providing the support and resources necessary to transform innovative ideas into impactful ventures. By partnering with promising startups andventure companies, we create win-win opportunities that pave the way for long-term success. With a global perspective, we actively seek value-driven investments that shape the future.

Investment focus

Artificial Intelligence, Software, Machine Learning
Series A, Series B, Seed
South Korea, United States, Singapore

Portfolio highlights

Medipal — Medipal provides personal health for a health consultation. It provides subscription-based personal nurse service for patients.
Gangnam Unni — Gangnam Unni is in the field of beauty medical services, helping users choose a treatment and a plastic surgery hospital. The difficulty of navigating the process of seeking medical treatment and choosing a hospital continues to persist. Kangnam Unni recognizes the need for change and firmly believes that a combination of transparent medicalinformation and an IT platform can foster a consumer-oriented medical service market. Their ultimate goal is to challenge negative perceptions surrounding plastic surgery and spearhead a significant transformation in the beauty and medical service industries.The Gangnam Unni team is dedicated to innovation, fueled by an unwavering desire to provide exceptional beauty and medical services. With the aim of assisting individuals in selecting a suitable hospital, they have amassed an impressive database of one million user reviews. Additionally, their efforts to promote transparency in medical information have garnered the support of 3,000 subscribers through Gangnam Sister. Furthermore, their mobile application has facilitated hospital consultations for a staggering 3.8 million individuals, resulting in 1.6 million successful cases.As the team continuously clarifies its mission and forges ahead with determination, its collective strength and resolve only grow stronger. Kangnam Unni remains committed to revolutionizing the healthcare industry, ensuring that individuals receive the highest quality of care and a positive experience throughout their medical journeys.
Healing Paper — Healing Paper is a mobile healthcare and information technology company.

Hana Financial Investment Company Limited offers brokerage, securities dealing, underwriting, mutual funds, and online trading services

Investment focus

Information Technology, Biotechnology, Software
Series A, Series B, Funding Round
South Korea, Singapore, India

Portfolio highlights

Trustay — Trustay is a real estate asset management company.
Kimu Studio — Kimu discovers servant artists, plans education and exhibitions with the artist's unique sensibility.
Kuntian New Energy — Hebei Kuntian New Energy is a producer of anode materials for lithium-ion batteries.

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Investment focus

Medical, Biotechnology, Health Care
Seed, Funding Round, Series A
China, United States, United Kingdom

Portfolio highlights

Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
Tuanxiang Pharmaceutical — Tuanxiang Pharmaceutical is an innovative drug research and development company that combines traditional new drug research and development with the use of the world's leading unique phase separation technology.
Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.

Nestle manufactures and sells food and beverages for several countries. It has generated more than CHF 90 billion in annual revenue. Its diverse product portfolio includes brands such as Nestle, Nescafe, Perrier, Pure Life, and Purina. Nestle also owns just over 23% of French cosmetics firm L'Oréal. It has a vast portfolio of global products,with 34 brands each achieving more than CHF 1 billion in sales annually and a geographic presence that spans 189 countries.

Investment focus

Food and Beverage, Health Care, Food Processing
Grant, Funding Round, Private Equity
United States, Germany, United Kingdom

Portfolio highlights

Wonder — Introducing a new kind of home dining experience. Currently available in areas of New Jersey.
Hsu Fu Chi — Hsu Fu Chi is a confectionery company that manufactures various confectionaries, biscuits, chocolates, jellies, sachima, and snacks.
yfood Labs — yfood Labs is a food-tech startup which designs smart food solutions for a modern generation. The product portfolio currently compromises ultra-convenient and complete-nutrition drinks, drink powders and bars.

Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, Ireland, Singapore

Portfolio highlights

Earlens — Earlens is the world's first and only hearing aid solution to directly vibrate the eardrum, delivering a more complete sound than any other hearing aid.
Claret Medical — Claret Medical, Inc. develops a series of cerebral vascular protection systems for transcatheter aortic valve implantation, surgical, and other interventional procedures. The company’s products include Claret Medical Montage, a dual filter system and percutaneously delivered embolic protection device to capture and remove debris disloged duringvascular procedures; and small (6F) catheters that are inserted into the patient's right arm to protect the patient’s brain during interventional procedures where embolic debris might be released. It offers its products for use as an embolic protection system to capture and remove embolic material (thrombus/debris) that may enter the cerebral vascular system during endovascular procedures. The company was incorporated in 2009 and is based in Santa Rosa, California.
ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.

M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.

Investment focus

Health Care, Software, Food and Beverage
Funding Round, Seed, Series A
France, United States, Canada

Portfolio highlights

Fasst — Fasst is involved in the creation, distribution, consulting, and connection of unique digital insurance solutions for brokers and insurers.
Hakbah — Hakbah is a Fintech startup focusing on an alternative financial saving. Hakbah is modernizing financial saving via its intelligent platform by offering a comprehensive one-stop-shop solution for Savings Groups to initiate, manage, join, and pay directly within the mobile app.
Demether — Demether is a DeFi protocol that works to enable zero-cost access to TVL for blockchains.

TVC is a transformational, early-stage venture firm backed by world class entrepreneurs and business leaders.

Investment focus

Health Care, Biotechnology, Artificial Intelligence
Seed, Series A, Pre-Seed
United States, United Kingdom, Germany

Portfolio highlights

SimpliFed — SimpliFed provides virtual breastfeeding and baby feeding support fully covered by your health plan from pregnancy to weaning.
Concert Bio — Concert Bio helps businesses manage their microbiome. We combine monitoring with analytics to develop interventions that improve the microbiome that matters to you. Our pilot program for CEA growers is currently live and accepting partners, see website for details.
Noda — Infogrid Helps Facilities Management And Estate Owners Deliver Truly Smart Buildings. Our Unique IoT Smart Sensors Can Be Installed In Seconds And Provide Automation And Optimization To Save You Time And Money.

Anzu Partners is an investment firm that focuses on industrial and life science technology companies with the potential to transform their industry. Anzu's portfolio support platform is dedicated to drive results beyond our initial investment and establish long-term relationships. We team with entrepreneurs to develop and commercializetechnological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. .Co-founders Whitney Haring-Smith, David Michael, and David Seldin launched the firm in 2014 in Washington, District of Columbia.

Investment focus

Biotechnology, Software, Manufacturing
Series A, Series B, Funding Round
United States, Canada, Spain

Portfolio highlights

6K — WHERE INDUSTRY 4.0 MEETS SUSTAINABLE PRODUCTION OF BREAKTHROUGH MATERIALS
e-Zinc — Founded in 2012, e-Zinc is a Toronto, Canada, based corporation that has developed a breakthrough electrochemical technology for storing energy in zinc metal. This low-cost, flexible, and long-duration energy storage solution will provide the platform for the world’s energy markets to be fully powered by renewable energy, enabling a zero-carbonenergy future.
CytoTronics — CytoTronics is designing and developing cell culture plates with embedded high-density electronic systems.

K3 Ventures provides venture capital for technology startups in various sectors such as finance, education, healthcare, food and agriculture and others. The firm is headed by Kuok Meng Xiong.

Investment focus

Financial Services, FinTech, Software
Series A, Seed, Funding Round
Singapore, United States, Indonesia

Portfolio highlights

WIZ.AI — WIZ.AI Talkbot is a leading Generative AI-powered omnichannel customer engagement solution for enterprises to propel business growth.
iEduGPT — iEduGPT is an AI-powered learning platform based in Singapore that offers personalized, adaptive learning solutions for professional and academic exam preparation. It leverages artificial intelligence to analyze individual learners' strengths and knowledge gaps and create optimized study paths. The platform aims to transform exam preparationby making learning smarter, more efficient, and tailored to each user’s unique needs, covering certifications in finance, academics, and languages.
Rekosistem — Rekosistem is a Clean- & Climate-Tech Company that enables circular economy implementation in the waste supply chain by leveraging proprietary waste management operation systems to transform waste into recycled materials and renewable resources.

SK Securities is a South Korea-based financial service provider that specializes in the securities market. It primarily engaged in securities brokerage, dealing and underwriting businesses, covering stocks, futures, options, government bonds, corporate bonds, foreign exchanges, and financial derivative products. The company also involves in theinvestment banking business, which provides acquisition, project financing services, and wealth management services.SK Securities was founded in 1955.

Investment focus

Information Technology, Apps, Health Care
Series A, Seed, Series B
South Korea, United States, Singapore

Portfolio highlights

DSRV — DSRV, a leading blockchain infrastructure company, offers A-Z solutions across the entire ecosystem for 160+ institutions through vertical integration of technologies such as staking, custody, and validators.
Hutom — Reshaping Surgery Through Digital Innovation
Soft Berry — Soft Berry is an electric vehicle charging platform.

As a responsible and long-term partner, they aim to make various constructive contributions to portfolio companies.

Investment focus

Biotechnology, Health Care, Software
Series B, Series A, Series C
South Korea, United States, Japan

Portfolio highlights

ASWEMAKE — ASWEMAKE is a shopping app that delivers groceries.
Dime Bio — Dime Bio is a drug development company for novel dementia treatments.
Arbor Biotechnologies — Arbor Biotechnologies is an early stage life sciences company pushing the boundaries of biodiscovery. Using artificial intelligence, genome sequencing, gene synthesis and high-throughput screening, we are accelerating the discovery of proteins for improving human health and sustainability.

KB Financial Group is Korea’s leading financial institution with the largest customer base and the most extensive branch network in the country. With total assets exceeding US$342 billion, the Group wields a solid capital prowess and enjoys a strong brand loyalty. As of December 2012, the Group has ten domestic subsidiaries--banking, credit cards,securities, life insurance, asset management, real estate trust, venture capital, credit information, data system, and savings bank--and four overseas subsidiaries in Hong Kong, England, Cambodia, and China.KB Financial Group was established in September 2008 with extensive stock transfers from major subsidiary companies. The Group’s establishment was to better deal with such fundamental changes in the financial markets at home and abroad as the rapid globalization of financial service, a declining profitability of traditional banking operations, new industry regulations, and an increasing demand for comprehensive financial services.

Investment focus

Financial Services, Software, SaaS
Series A, Series B, Seed
South Korea, India, Vietnam

Portfolio highlights

Nitra — Nitra offers expense management software that integrates with the banks to provide innovative loan products.
Wavebridge — Wavebridge is a top institutional digital asset company with traditional financial knowhows and crypto finance technology. The company was established in November 2018 to provide a comprehensive suite of investment solutions utilizing its data processing and AI technology.
BlockOdyssey — BlockOdyssey is a tech start-up that provides 'blockchain-based B2B solutions'.Currently, the main solution is supplying 'blockchain-based anti-counterfeiting solution', and logistics & distribution history management is in progress with blockchain. It has received investment from Asia's largest cosmetic company, andis conducting business with French pharmaceutical companies.

Amgen Ventures is a venture capital investment arm of Amgen Inc. specializing in investments in early and later stage companies. The firm primarily invests in the biotechnology sector with a focus on discovering and developing human therapeutics with a focus on oncology, inflammation, hematology, nephrology, metabolic disorders, neuroscience, andcardiovascular therapeutics. In oncology and hematology it focuses on novel therapeutics including signal transduction, cell cycle, and apoptosis; hematopoiesis including anemia, neutropenia, and stem cell mobilization; and supportive care including mucositis and cachexia. In nephrology the firm focuses on renal failure and hyperparathyroidism. For inflammation the firm focuses on rheumatoid arthritis, psoriasis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, asthma and COPD, and osteoarthritis. Under cardiovascular, it focuses on acute coronary syndromes, dyslipidemia, and heart failure and under metabolic disorders it focuses on diabetes, metabolic syndrome, and osteoporosis. The focus on neuroscience included pain including neuropathic and inflammatory, alzheimer's disease, parkinson's disease, sleep disorder, cognition, and schizophrenia. In discovery research and technology the firm focuses on early-stage drug discovery collaborations, innovative chemical entity collections, diagnostics and biomarkers, novel antibody platforms, assay biologicals and devices, and target-focused structural biology and computational tools. It primarily invests in the North America, Europe, and the United Kingdom. The firm typically invests between $2 million and $3 million per transaction and may invest up to $10 million per company. It prefers to have an ownership stake of less than 15 % in its portfolio companies. Amgen Ventures was founded in 2004 and is based in San Francisco, California with additional offices in Seattle, Washington; Thousand Oaks, California; and Cambridge, Massachusetts.

Investment focus

Biotechnology, Health Care, Therapeutics
Series B, Series A, Series C
United States, Canada, United Kingdom

Portfolio highlights

Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
Feldan Therapeutics — Feldan Therapeutics has developed a patented peptide-based technology platform, the Feldan Shuttle, which enables fast and safe intracellular delivery. The company's mission is to develop leading-edge therapeutic applications based on its proprietary platform, as demonstrated by its current pipeline of clinical programs taking advantage of theunique characteristics of the Shuttle.
Mindset Medical — Mindset Medical is a Health Care Company that develops a platform for clinical information. Through their platform physicians will understand patient pain, saves time for providers and patients, they eliminate paper and redundant forms, and allows providers more time for patients. Mindset Medical was founded in 2016 in Phoenix, Arizona.

UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Funding Round
Japan, United States, India

Portfolio highlights

Piece — Piece is a digital real estate platform offering the easiest and most transparent way to participate in income-producing real estate in Europe. Our mission is to make real estate ownership inclusive and more accessible.
Forest — Forest Co., Ltd. operates as an e-commerce aggregator, seeks to identify sustainable, high-quality products and brands that embrace the spirit of Japan and help them grow and enter the global market by using the power of technology.
Celaid Therapeutics — Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.

Openspace Ventures is a leading venture capital firm finding and backing Southeast Asian companies creating a transformative impact where tech meets life.

Investment focus

E-Commerce, Financial Services, Artificial Intelligence
Series A, Series B, Seed
Singapore, Indonesia, Philippines

Portfolio highlights

Every Half Coffee Roasters — Roasting & Brewing finest quality of specialty coffee bean from Vietnam and the world. We believe that every half bean has its soulmate. Let's find yours
Jiwa Group — PT Luna Boga Narayan
Octopus — Octopus.co.id adalah portal berita dan informasi terbaru yang memiliki visi untuk memberikan informasi yang akurat, terkini, dan bermanfaat.

Investors by industry

Community

Artificial intelligence